Process and test kit for determining free active compounds in biological fluids

US5714336A · kind A · utility

Assignee

• Hoechst GmbH · DE

Inventors

• Guido Simons · Ingelheim am Rhein, DE
• Helmut Strecker · Seeheim-Jugenheim, DE
• Peter Molz · Mainz, DE
• Gerd Schnorr · Bad Vilbel, DE
• Heinz Jurgen Skrzipczyk · Walldorf, DE
• Hans Wissmann · Bad Soden am Taunus, DE

Key dates

• Filing date: May 18, 1992
• Grant date: Feb 3, 1998
• Expiry date: May 18, 2012

Classification

• Technology area (CPC G): Physics
• CPC primary: G01N33/78
• WIPO field: Measurement
• WIPO sector: Instruments

Abstract

A method for determining the concentration of the free fraction of an active compound, present in a biological fluid, in the presence of natural binders, the free and bound fractions of the active compound being in mutual equilibrium, by PA1 a) contacting a sample of the fluid with an unlabeled antibody, PA1 b) separating the sample from the unlabeled antibody, PA1 c) incubating the unlabeled antibody with a labeled substance (tracer) for cross-reaction with the antibody and PA1 d) measuring the amount of the tracer which is or is not bound to the antibody and calculating from this the concentration of the free fraction of the active compound, PA1 wherein the quantity of the unlabeled antibody and/or its affinity for the active compound are so small that they do not substantially effect the equilibrium between the free and bound fractions of the active compound, and the affinity of the tracer for the antibody is substantially higher or substantially lower than that of the active compound itself, and a test kit suitable for this method.